MNOV MediciNova Inc.

6.18
+0.30  (5%)
Previous Close 5.88
Open 6.03
Price To book 6.51
Market Cap 216724331
Shares 35,068,662
Volume 139,570
Short Ratio 70.03
Av. Daily Volume 44,538

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b top-line data to be presented October 28, 2017 at Joint ECTRIMS – ACTRIMS meeting.
MN-166
Progressive multiple sclerosis (progressive MS)
Phase 2 planned
MN-001
NASH (nonalcoholic steatohepatitis)
Phase 2 completion of enrollment noted September 19, 2017. Final data due 1Q 2018.
MN-166
Opioid dependence
Phase 2 interim data released April 2016
MN-166
Amyotrophic lateral sclerosis (ALS)